Avalo Study
A Phase 2, Randomized, Double-blind, Placebocontrolled, Parallel-group Study to Evaluate the Efficacy and Safety of AVTX-009 in Patients with Moderate to Severe Hidradenitis Suppurativa (LOTUS)
- Sex: Any
- Age: Adult (18 - 64), Older Adult (65+)
- Accepting Healthy People: No
- Type: Interventional / Therapeutic
- Trial Phase: Phase II
- Conditions Being Studied: Hidradenitis Suppurativa (HS)
Study Purpose
The main purpose of this study is to evaluate the efficacy and safety of investigational drug, AVTX-009, compared with placebo in patients with moderate to severe Hidradenitis Suppurativa (HS).
Who Can Participate
Participants 18 years and older with symptoms of hidradenitis suppurativa (HS) for at least 6 months prior to screening may be eligible for this study.
Locations
UH Cleveland Medical Center
11100 Euclid Ave
Cleveland OH, 44106
- UH IRB: STUDY20241432
- StudyID: 2024-01582
- ClinicalTrials.gov: NCT06603077
Questions or concerns? We're here to help.
Non-cancer Trials: 1-833-78TRIAL or Contact Us Online
Cancer Trials: 1-800-641-2422